Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease 2”

350 trials

Showing 20 of 350 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04380636
What this trial is testing

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 870
Not applicableLooking for participantsNCT06323564
What this trial is testing

Exploring Emotional Intelligence and Cognitive Flexibility in Anorexia Nervosa and Parkinson's Disease.

Who this might be right for
Anorexia NervosaParkinson Disease
Istituto Auxologico Italiano 80
Not applicableLooking for participantsNCT04366804
What this trial is testing

International Validation of Two Non-motor Scales in PD (NFS and SPARK)

Who this might be right for
Parkinson's DiseaseNon-motor Symptoms
Insel Gruppe AG, University Hospital Bern 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT03683225
What this trial is testing

Evaluate in Patients With Parkinsonian Type Disorders

Who this might be right for
Idiopathic Parkinson Disease
Chase Therapeutics Corporation 24
Testing effectiveness (Phase 2)Study completedNCT00610103
What this trial is testing

Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy

Who this might be right for
Parkinson's Disease
Kyowa Kirin Co., Ltd. 16
Early research (Phase 1)Study completedNCT01338896
What this trial is testing

Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations

Who this might be right for
Parkinson's Disease
UCB Pharma 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05931484
What this trial is testing

Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.

Who this might be right for
Parkinson Disease
Forest Hills Lab 32
Large-scale testing (Phase 3)Study completedNCT00474058
What this trial is testing

Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine

Who this might be right for
Parkinson's Disease
UCB Pharma 287
Testing effectiveness (Phase 2)Study completedNCT03322540
What this trial is testing

Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)

Who this might be right for
Lung Cancer
Incyte Corporation 154
Testing effectiveness (Phase 2)UnknownNCT03576638
What this trial is testing

Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Intec Pharma Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT00857532
What this trial is testing

Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Avid Radiopharmaceuticals 31
Not applicableUnknownNCT04033393
What this trial is testing

Dual-task Performance in Young-onset PD

Who this might be right for
Early Onset Parkinson DiseaseEarly Stage Parkinson Disease
National Yang Ming Chiao Tung University 40
Testing effectiveness (Phase 2)Ended earlyNCT04521621
What this trial is testing

Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013)

Who this might be right for
Neoplasm Metastasis
Merck Sharp & Dohme LLC 76
Testing effectiveness (Phase 2)Study completedNCT03776136
What this trial is testing

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)

Who this might be right for
Advanced Melanoma
Merck Sharp & Dohme LLC 103
Large-scale testing (Phase 3)Study completedNCT03829332
What this trial is testing

Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) (MK-7902-007/E7080-G000-314/LEAP-007)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 623
Early research (Phase 1)Study completedNCT01964573
What this trial is testing

Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects

Who this might be right for
Parkinson's Disease
UCB Pharma 48
Testing effectiveness (Phase 2)Study completedNCT02910102
What this trial is testing

Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia

Who this might be right for
Alzheimer's DiseaseDementia With Lewy BodiesParkinson's Disease Dementia
Axovant Sciences Ltd. 38
Large-scale testing (Phase 3)Looking for participantsNCT05239741
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)

Who this might be right for
Colorectal Neoplasms
Merck Sharp & Dohme LLC 100
Post-approval studies (Phase 4)Ended earlyNCT01244269
What this trial is testing

The Effect of Methylphenidate on Non-motor Symptoms and Postural Control in Parkinson's Disease.

Who this might be right for
Parkinson's Disease
Laval University 6
Large-scale testing (Phase 3)Active Not RecruitingNCT05239728
What this trial is testing

Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 1,800
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation